Chan Li

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Yong Rao, Zhi-qi Kuang, Chan Li, 2021, Gut microbes.

Bouchardatine suppresses rectal cancer in mice by disrupting its metabolic pathways via activating the SIRT1-PGC-1α-UCP2 axis.

Ji-Ming Ye, Yong Rao, Chan Li, 2019, European journal of pharmacology.

Discovery of a promising agent IQZ23 for the treatment of obesity and related metabolic disorders.

Ji-Ming Ye, Yong Rao, Chan Li, 2020, European journal of medicinal chemistry.

Euphorhelipanes A and B, Triglyceride-Lowering Euphorbia Diterpenoids with a Bicyclo[4.3.0]nonane Core from Euphorbia helioscopia.

Yong Rao, Chan Li, Zhishu Huang, 2019, Journal of natural products.

Matrine counteracts obesity in mice via inducing adipose thermogenesis by activating HSF1/PGC-1α axis.

Xiu Zhou, Yong Rao, Chan Li, 2022, Pharmacological research.

Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity

Yong Rao, Chan Li, Yao-Hao Xu, 2019, British journal of pharmacology.

A novel HSF1 activator ameliorates non‐alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation

Shiying Guo, Yong Rao, Chan Li, 2021, British journal of pharmacology.

Bouchardatine analogue alleviates NAFLD/NASH in high fat fed mice via blunting ATP synthase activity.

Yong Rao, Chan Li, Yao-Hao Xu, 2019, British journal of pharmacology.